Global Organ Transplant Immunosuppressant Market 2017-2021

Global Organ Transplant Immunosuppressant Market 2017-2021

  • July 2017 •
  • 128 pages •
  • Report ID: 4988886 •
  • Format: PDF
About Organ Transplant Immunosuppressant

An organ transplantation is a surgical procedure that involves replacing diseased organs such as a heart, liver, kidney, or lung with healthy organs. The donor organ can come from a deceased donor (who has recently passed away) such as in heart transplants, or kidney, liver, and rarely lung transplants from living donors. As per the Centers for Disease Control and Prevention (CDC) report, the most commonly transplanted organs in the US are the kidney, liver, heart, lungs, pancreas, and intestine. On any given day, there are about 75,000 people on active waiting list for organ transplantation. However, the organ donors are very few, leading to the high unmet need for organ availability. There are only 8,000 deceased organ donors annually, with each providing on average 3.5 organs. Living donors provide on average only around 6,000 organs per year.

Technavio’s analysts forecast the global organ transplant immunosuppressant market to grow at a CAGR of 3.81% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global organ transplant immunosuppressant market for 2017-2021. To calculate the market size, the report considers the sales of both branded and generic drugs.

The market is divided into the following segments based on geography:
• Americas

Technavio’s report, Global Organ Transplant Immunosuppressant Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Novartis,
• Astellas Pharma,
• Pfizer,
• Sanofi,
Other prominent vendors
• AbbVie
• Bristol-Myers Squibb
• F. Hoffmann-La Roche

Market driver
• Increased incidence of organ failure
• For a full, detailed list, view our report

Market challenge
• Insufficient organ supply
• For a full, detailed list, view our report

Market trend
• Growing trend of medical tourism
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


We are very sorry, but an error occurred.
Please contact if the problem remains.